Skip to content
healthcare.dev

RAPIBLYK

NDC 84381-110, landiolol, injection, powder, lyophilized, for solution, from AOP Orphan Pharmaceuticals GmbH.

Product NDC
84381-110
Status
Listed
Labeler
AOP Orphan Pharmaceuticals GmbH
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA217202
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/84381-110 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LANDIOLOL HYDROCHLORIDE280 mg/1

Pharmacologic classes

Adrenergic beta1-Antagonists [MoA]; beta-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
84381-110-01843810110011 VIAL, SINGLE-DOSE in 1 CARTON (84381-110-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/27e7f20f-78a4-f1a9-e063-6394a90ae465

Use it

Look up 84381-110 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/84381-110 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 84381-110. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.